By Jeremiah Velasquez, FNP-BC, AGACNP-BC
Founder, Steel City HRT & Weight Loss | Board-Certified Family & Acute Care Nurse Practitioner
NPI: 1841894003

Semaglutide and other GLP-1 receptor agonists produce clinically significant weight loss, but without protective co-interventions, research suggests up to 39–40% of weight lost may come from lean muscle tissue rather than fat. Maintaining optimal testosterone levels and incorporating clinically supervised peptide therapy sourced from licensed 503a compounding pharmacies may help preserve muscle mass and improve body composition outcomes during GLP-1 treatment.

Nobody told you the whole story.

You heard that semaglutide could help you lose the weight you've been carrying for years. You've seen the numbers — 15%, 20% of total body weight gone in under a year. And maybe it's already working. The scale is moving, your clothes fit differently, and for the first time in a while, you feel like something is actually happening.

Here's what the system conveniently skipped: rapid, GLP-1-driven weight loss — particularly without the right protective co-interventions — doesn't just burn fat. It burns muscle. Research conducted within the STEP clinical trial program for semaglutide suggests that up to 39–40% of total weight lost can come directly from lean muscle tissue, not adipose fat, but the metabolically active, structurally critical tissue you've spent years earning.

That's not fat loss. That's body composition destruction dressed up as progress on a scale. For the men and women who finish a semaglutide program looking depleted, exhausted, and soft rather than lean and athletic, this explains everything.

There is a smarter approach. It starts with understanding what's actually happening inside your body — and the irreplaceable role that optimal testosterone plays in making sure what you're shedding is fat, not the tissue that keeps you strong, energized, and in the room.

What's Actually Happening to Your Muscles on Semaglutide?

You're not imagining it. The fatigue, the unexpected loss of strength, the frustrating feeling that despite losing weight you don't look or feel the way you expected — that is a clinical phenomenon, not a character flaw. The system that handed you a GLP-1 prescription without a word about muscle protection set you up for exactly this outcome.

Sarcopenia — defined as the progressive loss of skeletal muscle mass and physical function — is not a condition reserved for sedentary older adults. Any prolonged, severe caloric deficit can trigger the catabolic cascade that breaks muscle protein down for fuel. GLP-1 receptor agonists like semaglutide are extraordinarily effective at creating that deficit. That efficacy is also what makes unprotected use clinically risky from a body composition standpoint. According to analyses conducted in the context of the STEP clinical trial data, lean mass accounted for approximately 39% of total weight lost in participants without structured resistance training and hormone optimization protocols in place.

Here is what that process actually looks like in sequence. One: caloric intake drops sharply as appetite suppression kicks in — often well below the threshold required to sustain muscle protein synthesis. Two: the body, unable to meet its energy demands from fat stores alone at the rate GLP-1 drives, begins pulling from lean tissue as a secondary fuel source. Three: anabolic hormone levels — particularly testosterone — decline or remain suboptimal, removing the body's primary molecular brake against muscle breakdown. Four: the patient loses significant scale weight while simultaneously losing the tissue most responsible for metabolic rate, structural strength, and long-term body composition stability.

The result is what clinicians increasingly call a "skinny-fat" outcome. Smaller, yes. But softer, weaker, and with a slower metabolism that makes every pound of regain faster and harder to reverse.

Key takeaway: Rapid weight loss on GLP-1 receptor agonists like semaglutide can trigger significant lean muscle loss — estimated at 39–40% of total weight lost — through a catabolic process driven by severe caloric deficit compounded by suboptimal anabolic hormone levels.

Why Does Testosterone Protect Muscle During Rapid Fat Loss — And What Does the Science Say?

Here's what most people don't know. Testosterone is not simply a sex hormone. It is the body's primary anabolic signal — the molecular instruction that tells skeletal muscle cells to build, maintain, and protect lean tissue rather than sacrifice it for fuel.

When testosterone is suboptimal, that signal weakens. The brake on muscle catabolism releases. And when you layer a GLP-1-driven caloric deficit on top of already suboptimal testosterone, you are simultaneously pressing the accelerator on muscle wasting while the one mechanism built to resist it is compromised.

The mechanism is direct. Testosterone binds to androgen receptors in skeletal muscle cells, activating signaling pathways that drive muscle protein synthesis and inhibit proteolysis — the biochemical process by which the body breaks down muscle protein for energy. According to the Endocrine Society's clinical practice guidelines on testosterone therapy, men with suboptimal testosterone demonstrate significantly reduced muscle protein synthesis rates and accelerated lean mass loss, independent of caloric intake. When a severe caloric deficit is introduced on top of low or suboptimal testosterone, both drivers of muscle loss are active simultaneously — and the damage compounds.

Testosterone maintained in the clinically optimized range — generally 700–1,000 ng/dL by optimization standards rather than the population-average reference range most labs flag as "normal" — does the opposite. It preserves lean tissue during caloric restriction, supports muscle recovery in the context of resistance training, and directly improves insulin sensitivity, which helps the body preferentially oxidize fat as fuel rather than defaulting to lean tissue breakdown.

The analogy is straightforward: think of optimal testosterone as your body's construction crew. Without them on site, a storm — meaning the caloric deficit — tears the building down. With them operating at full capacity, the structure holds and can even be improved while the storm clears the debris.

Key takeaway: Optimal testosterone levels preserve lean muscle during caloric deficit by sustaining muscle protein synthesis pathways and inhibiting breakdown — making hormone optimization a clinically necessary protective layer for patients on GLP-1 therapy, not an optional add-on.

What Does a Muscle-Protective GLP-1 Protocol Actually Look Like?

Here's the thing about how most GLP-1 programs are structured: a prescription and a three-month follow-up is a conveyor belt. That's not care. That's a throughput system that outsources the outcomes to the patient and calls it medicine.

For the men and women left wondering why they lost 25 pounds and still don't like what they see in the mirror, the gap between that conveyor belt and an integrated metabolic optimization program is the entire answer.

An effective GLP-1 protocol built around body composition — not just scale weight — looks fundamentally different. Starting with a comprehensive hormone panel that establishes testosterone, IGF-1, and full metabolic baseline before any GLP-1 dosing begins, followed by concurrent testosterone optimization to maintain anabolic protection throughout the entire fat loss phase, followed by physician-supervised peptide therapy to provide a third layer of muscle preservation and recovery support, and ending with ongoing lab and biometric monitoring so the clinical picture is never a months-old guess.

One: baseline labs — total and free testosterone, IGF-1, CMP, CBC, HbA1c. This is not a box-checking exercise. It's the foundation every clinical decision is built on. Two: GLP-1 therapy initiated with simultaneous hormone optimization — not prescribed as a separate conversation three years later. Three: muscle-sparing peptide therapy sourced from licensed 503a compounding pharmacies, under direct clinical supervision, as a third anabolic layer during the catabolic phase of rapid fat loss. Four: ongoing monitoring that tracks body composition alongside scale weight, so the program responds to what's actually happening rather than to a number.

On the subject of peptides, this distinction matters and it will not be understated: the internet is saturated with "research-use-only" (RUO) peptides marketed directly to consumers seeking weight loss and performance results. RUO compounds are explicitly designated as not intended for human use. That is not a technicality — it is the legal classification. These substances are not manufactured under USP 797 sterility requirements, are not subject to pharmaceutical-grade potency verification, and carry no safety profile applicable to clinical use. The difference between a 503a-compounded peptide from a licensed pharmacy and an RUO compound purchased online is not regulatory paperwork. It is the difference between a supervised clinical intervention and an unverified substance of unknown purity being injected into your body.

You have two options here. Continue on a program that shrinks the scale while quietly destroying the body composition you worked to build. Or take the integrated approach — with hormone protection, verified sourcing, and a provider monitoring every layer of the process.

Key takeaway: Effective GLP-1 metabolic optimization for body composition requires concurrent testosterone optimization, resistance training guidance, and clinically supervised peptide therapy from licensed 503a compounding pharmacies — GLP-1 therapy alone is insufficient to protect lean mass during rapid weight loss.

Why Are Patients Choosing Steel City HRT & Weight Loss for GLP-1 Metabolic Optimization?

I've been on both sides of this. I've been the patient who watched weight loss feel like a loss of something else — strength, energy, the physicality I'd worked for. And I've been the provider who has seen, consistently, what integrated hormone and metabolic optimization produces versus what a prescription-and-goodbye approach delivers. There is no comparison.

Steel City HRT & Weight Loss is LegitScript-certified — the same verification standard used by major national pharmacy chains and insurance platforms to confirm regulatory compliance and clinical legitimacy. We are a fully telehealth practice licensed across ten states: Colorado, Arizona, Washington, Idaho, Maine, Montana, New Hampshire, New Mexico, Arkansas, and Wyoming. No clinic visit required.

What makes the Steel City GLP-1 Metabolic Optimization program distinct is integration. Semaglutide sourced exclusively from 503a compounding pharmacies — never RUO, never unverified grey-market compounds. Testosterone optimization running concurrently for patients with suboptimal hormone levels, not addressed years later when patients ask why they feel depleted. Muscle-sparing peptide protocols compounded under USP 797 standards and supervised by a board-certified provider. And ongoing monitoring through our HIPAA-secure app, so the clinical picture between labs is never a guess.

As board-certified Family and Acute Care Nurse Practitioner Jeremiah Velasquez, FNP-BC, AGACNP-BC: we don't treat lab values and we don't treat scale numbers. We treat the patient in front of us — and that patient deserves to finish this process looking lean and athletic, not exhausted and defeated.

Ready to Build a Weight Loss Program That Protects Your Muscle?

Patients across our ten licensed states are accessing GLP-1 metabolic optimization the right way — with hormone protection in place, 503a-sourced medications, and a provider monitoring the full clinical picture from start to finish. No waiting rooms. No unanswered questions. No prescription followed by silence.

You can keep following a program that moves the scale while quietly destroying the body composition you've built. Or you can do this with every protective layer in place from day one.

Labs, consult, optimization — that easy. It all starts at steelcity-trt.com.

Frequently Asked Questions

Q: Does semaglutide cause muscle loss? A: Yes. Research on the STEP clinical trial program indicates that lean muscle tissue can account for approximately 39–40% of total weight lost on semaglutide without protective interventions. Concurrent testosterone optimization, resistance training, adequate protein intake, and clinically supervised peptide therapy sourced from 503a compounding pharmacies may significantly reduce lean mass loss during GLP-1 treatment.

Q: Can testosterone protect muscle during semaglutide therapy? A: Testosterone is the body's primary anabolic signal for skeletal muscle. According to the Endocrine Society's clinical guidelines, suboptimal testosterone is associated with reduced muscle protein synthesis and accelerated lean mass loss. Maintaining testosterone in the clinically optimized range of 700–1,000 ng/dL during GLP-1 therapy may help the body preferentially burn fat rather than lean tissue during caloric deficit.

Q: What is sarcopenia and why does it matter during weight loss? A: Sarcopenia is the progressive loss of skeletal muscle mass and functional strength. During rapid caloric deficit — including GLP-1-induced deficit — the body can break down lean muscle as a secondary fuel source. This matters because muscle drives metabolic rate; losing significant lean mass during weight loss typically accelerates fat regain after treatment ends and leaves patients in a worse metabolic position than when they started.

Q: Are peptides safe to use during semaglutide treatment for muscle preservation? A: Peptide therapy may support muscle preservation during GLP-1-driven weight loss when sourced from licensed 503a compounding pharmacies and supervised by a qualified clinical provider. Research-use-only (RUO) peptides — widely sold online — are not manufactured to human-use standards and carry unknown potency, sterility, and safety profiles. Clinically compounded peptides from 503a pharmacies are subject to USP 797 pharmaceutical standards; RUO compounds are not.

Q: Is it possible to lose fat while maintaining muscle on semaglutide? A: Yes, with integrated co-interventions. Concurrent testosterone optimization, structured resistance training, targeted protein intake, and physician-supervised peptide therapy from 503a-licensed pharmacies can collectively preserve lean mass — and in some cases support modest muscle gain — while semaglutide drives fat loss. This outcome requires an integrated protocol, not GLP-1 therapy in isolation.

Q: Is Steel City HRT & Weight Loss available for telehealth GLP-1 patients? A: Steel City HRT & Weight Loss is a LegitScript-certified telehealth clinic licensed in Colorado, Arizona, Washington, Idaho, Maine, Montana, New Hampshire, New Mexico, Arkansas, and Wyoming. GLP-1 metabolic optimization, testosterone therapy, and clinical peptide protocols are all available via telehealth with no in-person clinic visit required.

This content is for informational purposes only and does not constitute medical advice. Consult a licensed provider before beginning any hormone or weight loss therapy. Jeremiah Velasquez, FNP-BC, AGACNP-BC, is a licensed nurse practitioner. Steel City HRT & Weight Loss is a LegitScript-certified telehealth clinic.